Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jonathan Seaton, Mark Boyle, and Aarush Manchanda

Jonathan Seaton

Illumina has appointed Jonathan Seaton as senior VP for corporate and business development. In this role, Seaton will be responsible for global business development activities, including strategic commercial deals, mergers and acquisitions, licensing, and partnerships. He joins Illumina from Becton Dickinson, where he was VP and head of strategy and business development for the Life Sciences segment. He previously held leadership roles at Hoffman-La Roche, Roche Tissue Diagnostics, LS9, and several consulting firms and investment banks.

Mark Boyle

Clinical Genomics has appointed Mark Boyle as president of in vitro diagnostics. Boyle joins Clinical Genomics from Qiagen, where he served as a VP for nearly five years. Previously, he served as president of Cellestis, prior to that firm's acquisition by Qiagen and successful integration into the company. He has also served as general manager for the UK subsidiary of Diagnostics Systems Laboratories.

Aarush Manchanda

Portable Genomics has appointed Aarush Manchanda to its board of directors. Manchanda is board certified in internal medicine, cardiovascular disease, nuclear cardiology, cardiac computed tomography, and echocardiography. He currently works as a staff cardiologist at Cedar City Heart Clinic in Cedar City, Utah. He also serves as medical director of Cardiovascular Services at Cedar City Hospital.

For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.